New Formulation of Salicylate to Improve Treatment of Common Skin Warts
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
To determine if salicylate with ethyl pyruvate (SA-EP) eliminates plantar warts more quickly than salicylate (SA) alone.
Subjects' wart(s) are treated with SA or SA-EP every two weeks for up to 16 weeks.
Michael R Grossman, DPM
United States: Institutional Review Board
|Main Line Foot and Ankle Center||Ardmore, Pennsylvania 19003|